CELG.RT

Bristol-Myers Squibb Company Contingent Value Rights

18 hedge funds and large institutions have $5.17M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
3
Increased
4
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change